|
1
|
Scarpa M, Bertin M, Ruffolo C, Polese L,
D'Amico DF and Angriman I: A systemic review on the clinical
diagnosis of gastrointestinal stromal tumors. J Surg Oncol.
98:384–392. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miettinen M, Sarlomo-Rikala M and Lasota
J: Gastrointestinal stromal tumors: Recent advances in
understanding of their biology. Hum Pathol. 30:1213–1220. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fletcher CD, Berman JJ, Corless C,
Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti
H, Rubin BP, et al: Diagnosis of gastrointestinal stromal tumors: A
consensus approach. Int J Surg pathol. 10:81–99. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang HY, Li CF, Huang WW, Hu TH, Lin CN,
Uen YH, Hsiung CY and Lu D: A modification of NIH consensus
criteria to better distinguish the highly lethal subset of primary
localized gastrointestinal stromal tumors: A subdivision of the
original high-risk group on the basis of outcome. Surgery.
141:748–756. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Demetri GD, von Mehren M, Antonescu CR,
DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF,
Schuetze S, et al: NCCN task force report: Update on the management
of patients with gastrointestinal stromal tumors. J Natl Compr Canc
Netw. 8(Suppl 2): S1–S41. 2010.PubMed/NCBI
|
|
6
|
Joensuu H: Risk stratification of patients
diagnosed with gastro-intestinal stromal tumor. Hum Pathol.
39:1411–1419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors-definition, clinical, histological,
immunohistochemical and molecular genetic features and differential
diagnosis. Virchows Arch. 438:1–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miettinen M, Sobin LH and Lasota J:
Gastrointestinal stromal tumors of the stomach: A
clinicopathologic, immunohistochemical and molecular genetic study
of 1765 cases with long-term follow-up. Am J Surg Pathol. 29:52–68.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miettinen M, Makhlouf H, Sobin LH and
Lasota J: Gastrointestinal stromal tumors of the jejunum and ileum:
A clinicopathologic, immunohistochemical and molecular genetic
study of 906 cases before imatinib with long-term follow-up. Am J
Surg Pathol. 30:477–489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moiola C, De Luca P, Gardner K, Vazquez E
and De Siervi A: Cyclin T1 overexpression induces malignant
transformation and tumor growth. Cell Cycle. 9:3119–3126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Luca A, De Falco M, Baldi A and Paggi
MG: Cyclin T: Three forms for different roles in physiological and
pathological functions. J Cell Physiol. 194:101–107. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Luca A, Russo P, Severino A, Baldi A,
Battista T, Cavallotti I, De Luca L, Baldi F, Giordano A and Paggi
MG: Pattern of expression of cyclin T1 in human tissues. J
Histochem Cytochem. 49:685–692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sano M and Schneider MD: Cyclin-dependent
kinase-9: An RNAPII kinase at the nexus of cardiac growth and death
cascades. Circ Res. 95:867–876. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sano M, Wang SC, Shirai M, Scaglia F, Xie
M, Sakai S, Tanaka T, Kulkarni PA, Barger PM, Youker KA, et al:
Activation of cardiac Cdk9 represses PGC-1 and confers a
predisposition to heart failure. EMBO J. 23:3559–3569. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiu YL, Cao H, Jacque JM, Stevenson M and
Rana TM: Inhibition of human immunodeficiency virus type 1
replication by RNA interference directed against human
transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol.
78:2517–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chao SH and Price DH: Flavopiridol
inactivates P-TEFb and blocks most RNA polymerase II transcription
in vivo. J Biol Chem. 276:31793–31799. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Napolitano G, Majello B and Lania L: Role
of cyclinT/Cdk9 complex in basal and regulated transcription
(review). Int J Oncol. 21:171–177. 2002.PubMed/NCBI
|
|
18
|
Chen R, Keating MJ, Gandhi V and Plunkett
W: Transcription inhibition by flavopiridol: Mechanism of chronic
lymphocytic leukemia cell death. Blood. 106:2513–2519. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shan B, Zhuo Y, Chin D, Morris CA, Morris
GF and Lasky JA: Cyclin-dependent kinase 9 is required for tumor
necrosis factor-alpha-stimulated matrix metalloproteinase-9
expression in human lung adenocarcinoma cells. J Biol Chem.
280:1103–1111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nemoto Y, Mikami T, Hana K, Kikuchi S,
Kobayashi N, Watanabe M and Okayasu I: Correlation of enhanced cell
turnover with prognosis of gastrointestinal stromal tumors of the
stomach: relevance of cellularity and p27kip1. Pathol Int.
56:724–731. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu FY, Qi JP, Xu FL and Wu AP:
Clinicopathological and immunohistochemical analysis of
gastrointestinal stromal tumor. World J Gastroenterol.
12:4161–4165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koon N, Schneider-Stock R, Sarlomo-Rikala
M, Lasota J, Smolkin M, Petroni G, Zaika A, Boltze C, Meyer F,
Andersson L, et al: Molecular targets for tumour progression in
gastrointestinal stromal tumours. Gut. 53:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dorn J, Spatz H, Schmieder M, Barth TF,
Blatz A, Henne-Bruns D, Knippschild U and Kramer K: Cyclin H
expression is increased in GIST with very-high risk of malignancy.
BMC Cancer. 10:3502010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei YC, Chou FF, Li CF, Li WM, Chen YY,
Lan J, Li SH, Fang FM, Hu TH, Yu SC, et al: HuR cytoplasmic
expression is associated with increased cyclin A expression and
inferior disease-free survival in patients with gastrointestinal
stromal tumours (GISTs). Histopathology. 63:445–454.
2013.PubMed/NCBI
|
|
25
|
Rubin BP: Gastrointestinal stromal
tumours: An update. Histopathology. 48:83–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wong NA: Gastrointestinal stromal
tumours-an update for histopathologists. Histopathology.
59:807–821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
ESMO/European Sarcoma Network Working
Group: Gastrointestinal stromal tumors: ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol.
23(Suppl 7): vii. S49–S55. 2012.
|
|
28
|
Leucci E, De Falco G, Onnis A, Cerino G,
Cocco M, Luzzi A, Crupi D, Tigli C, Bellan C, Tosi P, et al: The
role of the Cdk9/cyclin T1 complex in T cell differentiation. J
Cell Physiol. 212:411–415. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bellan C, De Falco G, Lazzi S, Micheli P,
Vicidomini S, Schürfeld K, Amato T, Palumbo A, Bagella L, Sabattini
E, et al: CDK9/CYCLIN T1 expression during normal lymphoid
differentiation and malignant transformation. J Pathol.
203:946–952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
De Luca A, Russo P, Severino A, Baldi A,
Battista T, Cavallotti I, De Luca L, Baldi F, Giordano A and Paggi
MG: Pattern of expression of cyclin T1 in human tissues. J
Histochem Cytochem. 49:685–692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
MacLachlan TK, Sang N, De Luca A, Puri PL,
Levrero M and Giordano A: Binding of CDK9 to TRAF2. J Cell Biochem.
71:467–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peng J, Zhu Y, Milton JT and Price DH:
Identification of multiple cyclin subunits of human P-TEFb. Genes
Dev. 12:755–762. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Napolitano G, Majello B, Licciardo P,
Giordano A and Lania L: Transcriptional activity of positive
transcription elongation factor b kinase in vivo requires the
C-terminal domain of RNA polymerase II. Gene. 254:139–145. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen R, Keating MJ, Gandhi V and Plunkett
W: Transcription inhibition by flavopiridol: Mechanism of chronic
lymphocytic leukemia cell death. Blood. 106:2513–2519. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu TJ, Peng J, Lee G, Price DH and Flores
O: Cyclin K functions as a CDK9 regulatory subunit and
partici-pates in RNA polymerase II transcription. J Biol Chem.
274:34527–34530. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bettayeb K, Tirado OM, Marionneau-Lambot
S, Ferandin Y, Lozach O, Morris JC, Mateo-Lozano S, Drueckes P,
Schächtele C, Kubbutat MH, et al: Meriolins, a new class of cell
death inducing kinase inhibitors with enhanced selectivity for
cyclin-dependent kinases. Cancer Res. 67:8325–8334. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
De Falco G and Giordano A: CDK9: From
basal transcription to cancer and AIDS. Cancer Biol Ther.
1:342–347. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee DK, Duan HO and Chang C: Androgen
receptor interacts with the positive elongation factor P-TEFb and
enhances the efficiency of transcriptional elongation. J Biol Chem.
276:9978–9984. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garriga J, Peng J, Parreño M, Price DH,
Henderson EE and Graña X: Upregulation of cyclin T1/CDK9 complexes
during T cell activation. Oncogene. 17:3093–3102. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shirin H, Kravtsov V, Shahmurov M, Shabat
VS, Krinshpon I, Alin A, Avinoach I and Avni Y: The
cyclin-dependent kinase inhibitor, p27, has no correlation with the
malignant potential of GIST. Digestion. 75:4–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
